Article
High plasma levels of C1-inhibitor are associated with lower risk of future venous thromboembolism
31 Mar 2023
Abstract excerpt
BACKGROUND: C1-inhibitor (C1INH) is a broad-acting serine protease inhibitor with anticoagulant activity. The impact of C1INH plasma levels within the normal physiological range on risk of venous thromboembolism (VTE) is unknown. We assessed the association of plasma C1INH levels and VTE risk and evaluated the impact of C1INH on thrombin and plasmin generation in ex vivo assays. METHODS: A nested case-control...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
